Fundraising Fox
/Companies
Sign in

DexCom

NASDAQ: DXCM

San Diego, US · Delaware corporation · 9,000 employees on LinkedIn · 1 known investors

Find your way into DexCom

Each arrow is one introduction. Sign up to fill in the first one.

485 people can intro you to Sadie

Ask John McGaugh to introduce you to Sadie Stern

You →John · together at Sonendo®, Inc. →Sadie

179 people can intro you to Jon

Ask Jamie Chen to introduce you to Jon Coleman

You →Jamie · together at Masimo →Jon

Sign up to find every way you can get introduced to DexCom

  • Your email: who you already know at DexCom, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the DexCom team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Dexcom develops continuous glucose monitoring (CGM) systems and glucose biosensors, including the Dexcom G7 and the over-the-counter Stelo biosensor, that send real-time glucose readings to a phone or receiver. Its products serve people managing diabetes as well as consumers tracking glucose for general health, diet, and exercise.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

RD
Richard DoubledayExecutive
SRSteven R. Pacelli
Steven R. PacelliEVP & Managing Director, Dexcom Ventures2020–2025
JMJeffrey Moy
Jeffrey MoyExecutive
TH
Terrance H. GreggExecutive
JVJorge Valdes
Jorge ValdesChief Technology Officer2005–2017
JDJohn D. Lister
John D. ListerGeneral Manager, EMEA2015–2019
JRJess Roper
Jess RoperRetired CFO - Dexcom2005–2017Director at Revelation Biosciences
AK
Andrew K. BaloExecutive
JLJacob Leach
Jacob LeachPresident and Chief Executive Officer
JSJereme Sylvain
Jereme SylvainEVP, Chief Operating Officer
MBMichael Brown
Michael BrownExecutive Vice President, Chief Legal Officer
JCJon Coleman
Jon ColemanChief Commercial OfficerJon Coleman held executive leadership roles at Masimo, where he led global sales and operations and helped scale revenues to over $1 billion, as well as at Pfizer and Procter & Gamble in sales and international operations. He holds an MBA from Harvard Business School and a BA in International Relations from Brigham Young University.

Investors · 1

Reported raises · per SEC filings

Form D private placements

$7.2M disclosed across 1 round · 2016

▶$7.2MraisedMay 2016 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard DoubledayExecutive Officer
  • Eric TopolDirector
  • Barbara E. KahnDirector
  • Steven R. PacelliExecutive Officer
  • Jonathan T. LordDirector
  • Jeffrey MoyExecutive Officer
  • Nicholas AugustinosDirector
  • Terrance H. GreggExecutive Officer, Director
  • Jorge ValdesExecutive Officer
  • John D. ListerExecutive Officer
  • Jess RoperExecutive Officer
  • Andrew K. BaloExecutive Officer
  • Jay S. SkylerDirector
  • Kevin SayerExecutive Officer, Director
  • Steven R. AltmanDirector
  • Mark FolettaDirector
Offering amount
$7.2M
Amount sold
$7.2M
First sale
May 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

DiabetesA nonprofit organization that provides educational resources and information about prediabetes, including prevention strategies and lifestyle management for Americans at risk of developing type 2 diabetes.
NutrisenseNutrisense provides personalized metabolic monitoring and health guidance through continuous glucose monitoring and data analysis. The platform helps individuals understand their body's metabolic response to food and lifestyle choices to build sustainable health habits.
LarkLark develops an AI-powered health coaching platform that delivers personalized support for chronic disease prevention and management through 24/7 text-based conversations and integration with smart health devices. The platform serves individuals seeking affordable, accessible care for chronic conditions.

Companies working in the same space as DexCom.

Frequently asked questions

What does DexCom do?
Dexcom develops continuous glucose monitoring (CGM) systems and glucose biosensors, including the Dexcom G7 and the over-the-counter Stelo biosensor, that send real-time glucose readings to a phone or receiver. Its products serve people managing diabetes as well as consumers tracking glucose for general health, diet, and exercise.
Who are DexCom's investors?
DexCom's investors include Canaan Partners.
How much funding has DexCom raised?
DexCom has disclosed $7.2M raised across 1 round.
Where is DexCom headquartered?
DexCom is headquartered in San Diego, US.